Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06446128
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-06
First Post:
2024-05-16
Brief Title:
A Dose Escalating Study of CD19CD22BCMA CAR-T Therapy in Relapsed or Refractory B Cell Non-Hodgkin LymphomaNHL
Sponsor:
Shanghai Cell Therapy Group CoLtd
Organization:
Shanghai Cell Therapy Group CoLtd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04-01
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-07-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-16
First Submit QC Date:
May 31 2024
Study First Post Date:
2024-06-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-31
Last Update Post Date:
2024-06-06
Last Update Post Date Type:
ACTUAL